Home - Products - Others - Other Targets - GLP-1(7-37) acetate(106612-94-6 free base)

GLP-1(7-37) acetate(106612-94-6 free base)

CAS No. 1450806-98-0

GLP-1(7-37) acetate(106612-94-6 free base) ( —— )

Catalog No. M23617 CAS No. 1450806-98-0

Glp-1 (7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 205 In Stock
10MG 312 In Stock
25MG 530 In Stock
50MG 758 In Stock
100MG 1044 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GLP-1(7-37) acetate(106612-94-6 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    Glp-1 (7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
  • Description
    Glp-1 (7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1450806-98-0
  • Formula Weight
    3355.7
  • Molecular Formula
    C151H228N40O47
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C)C(N[C@@H](CC4=CNC5=CC=CC=C45)C(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(NCC(N[C@@H](CCCNC(N)=N)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC6=CNC=N6)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sarrauste de Menthiere, C. et al. Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production. European journal of medicinal chemistry 39, 473-480, doi:10.1016/j.ejmech.2004.02.002 (2004).
molnova catalog
related products
  • Lurbinectedin

    Lurbinectedin is a DNA minor groove covalent binder. Lurbinectedin also shows effective anti-tumor activity.

  • Senkirkine

    Senkirkin is a pyrrolizidine alkaloid with hepatotoxicity.

  • cilengtide

    cilengtide.